Latest News

The RUBIvet project is live!

What is the RUBIvet project? We have developed NANOPLEX™ technology for rapid identification of bacterial infections in 15 minutes. The RUBIvet project enables us to further diversify our R&D pipeline through…

Winner of the AMR Start-up Campus

FluoretiQ were honoured to present NANOPLEX™ at BIOCOM ‘s 4th Annual AMR Conference to an international audience of experts in Antimicrobials and AMR diagnostics. In an interview with CEO, Neciah…

Winners at the Launch Great West Awards

FluoretiQ are the winners of The People’s Choice Award at the Launch: Great West event The People’s Choice Award invites attendees to nominate their choice for the best scientific start-up…

Learn more about FluoretiQ

Menu